<DOC>
	<DOCNO>NCT02641743</DOCNO>
	<brief_summary>A carbohydrate adjust liquid formula ( Inslow ) use palatinose major carbohydrate ( &gt; 50 % ) devise . Consumption Inslow long term ( 3-5 month ) report improve glycemic control reduce postprandial plasma glucose level diabetes impaired glucose-tolerant subject ( IGT ) . The present study intend understand mechanism postprandial glycemic response .</brief_summary>
	<brief_title>Clinical Trial Liquid Food ( Inslow )</brief_title>
	<detailed_description>The test enteral nutrition formula ( Inslow ) standard balance formula ( Meibalance ) administer randomize crossover design 11 healthy people , 13 IGT 12 type-2 diabetes , judge postprandial state take two test meal random order washout period one week . On day prior test day , subject ask stay facility take supper 450 kcal control , 21:00 water allow ad libitum exercise . Each participant take fast blood sample , request consume one energetic test meal ( 200 kcal per serve ) Inslow standard balance formula 7:00 AM . Subsequent blood sample collect 30,60,90 , 120 min meal consumption . The plasma concentration glucose , insulin , free fatty acid measure blood sample . Plasma glucose measure hexokinase method , plasma insulin serum radioimmunoassay method plasma free fatty acid enzyme chemical method.Routine blood test biochemical test perform use blood sample fast stage , include RBC , WBC , TP , ALP , T-Cho , etc. , confirm status subject . Collected blood apply analyse Shanghai Meizhong Clinical Measurement Centre . The enteral nutrition meal Inslow design palatinose , dextrin fiber carbohydrate 56 % ,23 % 15 % , respectively . The standard balance meal include dextrin main carbohydrate 85 % , together sugar fiber .</detailed_description>
	<criteria>Type 2 diabetes ( symptom diabetes plus fast plasma glucose level high 7.0 mmol/L glucose level 75g oral glucose tolerance test ( OGTT ) casual blood glucose level high 11.1mmol/L ) IGT patient ( glucose level 75g OGTT 7.8 11.1mmol/L ) . These patient subject infectious disease use drug .</criteria>
	<gender>All</gender>
	<minimum_age>52 Years</minimum_age>
	<maximum_age>61 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>